Combined treatment for cataract and glaucoma treatment
US8882781B2 · kind B2 · utility
59Cited by
228References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 27, 2011 |
| Grant date | Nov 11, 2014 |
| Priority date | — |
| Expiry date | Oct 24, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61F9/00754
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A method is provided for treatment of cataract in combination with a glaucoma procedure while maintaining the intraocular pressure by permitting aqueous to flow out of an anterior chamber of the eye through a surgically stented pathway. A trabecular stent is adapted for implantation within the trabecular meshwork of an eye such that intraocular liquid flows controllably from the anterior chamber of the eye to Schlemm's canal, bypassing the trabecular meshwork. Depending upon the specific treatment contemplated, pharmaceuticals may be utilized in conjunction with the trabecular stent enabling post-cataract healing processes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.